Quanterix (QTRX) Stock: Buy, Sell, or Hold?
QTRX - Quanterix Corporation Common Stock
$3.06
-0.09 (-2.86%)
âŧ
5d:
-7.97%
30d:
+12.5%
90d:
-22.73%
WAIT
LOW Confidence
Analysis Updated: Oct 14, 2026 12:00 AM ET
Earnings: Nov 09, 2026
25d
Get Alerted When QTRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: QTRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: QTRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: QTRX is currently trading at $3.06, which is considered fair relative to its 30-day fair value range of $2.77 to $3.51.
Technical Outlook: Technically, QTRX is in a downtrend. The price is currently testing key support at $3.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: QTRX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QTRX is in a downtrend. The price is currently testing key support at $3.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: QTRX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.77 -
$3.51
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($3.00)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.77 -
$3.51
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.05
Resistance Level
$3.98
Current Trend
Downtrend
Technical data as of
Oct 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.32
Wall Street Target
$3.00
(-4.8%)
Revenue Growth (YoY)
34.4%
Profit Margin
-80.2%
Share & Embed Analysis
Last updated: October 14, 2026 4:55 PM ET
Data refreshes hourly during market hours. Next update: 5:55 PM
Data refreshes hourly during market hours. Next update: 5:55 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QTRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$60 | 61 BUY |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$364 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$104 | 51 HOLD |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$171 | 56 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 47 HOLD |
